Reckitt Benckiser Group (LON:RKT – Get Free Report) had its price objective increased by equities researchers at JPMorgan Chase & Co. from GBX 5,500 to GBX 6,100 in a note issued to investors on Wednesday, MarketBeat Ratings reports. The brokerage currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price would indicate a potential upside of 3.85% from the company’s previous close.
RKT has been the subject of several other research reports. Berenberg Bank reduced their price target on shares of Reckitt Benckiser Group from GBX 5,920 to GBX 5,555 and set a “hold” rating for the company in a report on Wednesday, August 6th. UBS Group reiterated a “buy” rating and issued a GBX 7,700 price objective on shares of Reckitt Benckiser Group in a research report on Friday, October 17th. Jefferies Financial Group reissued a “hold” rating and set a GBX 5,200 target price on shares of Reckitt Benckiser Group in a research note on Thursday, October 2nd. Royal Bank Of Canada raised their price target on shares of Reckitt Benckiser Group from GBX 6,000 to GBX 6,400 and gave the company an “outperform” rating in a research note on Thursday, October 23rd. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on Reckitt Benckiser Group from GBX 5,600 to GBX 5,700 and gave the company a “buy” rating in a report on Friday, October 24th. Three investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 6,109.17.
Reckitt Benckiser Group Trading Down 0.3%
Insider Buying and Selling at Reckitt Benckiser Group
In related news, insider Patricia Verduin purchased 135 shares of the company’s stock in a transaction that occurred on Wednesday, October 29th. The shares were purchased at an average price of GBX 5,867 per share, with a total value of £7,920.45. 0.42% of the stock is owned by company insiders.
About Reckitt Benckiser Group
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Further Reading
- Five stocks we like better than Reckitt Benckiser Group
- What Investors Need to Know About Upcoming IPOs
- Keysight Technologies’ Surge: The Market Wakes Up to This AI Play
- Overbought Stocks Explained: Should You Trade Them?
- Is American Express the Credit Stock For a K-Shaped Economy?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Powering Up: How a Credit Upgrade Fuels Vistra’s AI Ambitions
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
